化疗引起的腿部:一个案例系列
Marion Rousselot1, Emmanuel Mahé1, Patricia Senet2
1MD, Service de Dermatologie et Médecine Vasculaire, Centre Hospitalier Victor Dupouy, Argenteuil, France.
Journal of wound care
|March 6, 2025
概括
化疗,包括氨酸激酶抑制剂 (TKIs) 和税,可以导致腿部 (LUs). 这些出现在TKIs和taxan比氧尿素更快,但在停止治疗后迅速愈合.
科学领域:
- 在瘤学瘤学.
- 皮肤病学 皮肤病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 新的化疗药物,如氨酸激酶抑制剂 (TKIs),与皮肤副作用有关.
- 腿部 (LUs) 是某些化疗治疗的新兴问题.
研究的目的:
- 分析正在接受化疗的患者腿部的发展,特征和治疗方法.
- 在各种化疗类别中识别LU发病和表现的差异.
主要方法:
- 一项回顾性多中心研究,涉及法国9个皮肤病学和1个血液病学部门的45名患者.
- 收集的数据包括癌症史,LU辅因子,管理和演变.
- 患者被分为三组:氧尿素,向疗法 (包括TKI) 和税治疗.
主要成果:
- 腿部 (LUs) 显着更快地出现在与基尿素 (p<0.0001和p=0.004,分别) 相比,用税和TKIs治疗的患者中.
- 对于LUs的常见因素包括晚年,血管辅因子和疼痛.
- 在88%的病例中,化疗已被停止,其中91%的病例在平均4.6个月内实现了愈.
结论:
- 基尿素,向疗法 (TKIs) 和税都与腿部 (LUs) 的发展有关.
- 处方医生需要意识到这些化疗引起的皮肤毒性.
- 对LU辅因子的监测至关重要,特别是在具有先前存在的LU风险因素的患者中,应该考虑停止化疗的风险益处.
相关概念视频
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Peptic Ulcer Disease IV: Management
57
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
57
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
171
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
171


